tradingkey.logo

Neogenomics Inc

NEO
11.420USD
+0.150+1.33%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
1.47BCap. mercado
PérdidaP/E TTM

Neogenomics Inc

11.420
+0.150+1.33%

Más Datos de Neogenomics Inc Compañía

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Información de Neogenomics Inc

Símbolo de cotizaciónNEO
Nombre de la empresaNeogenomics Inc
Fecha de salida a bolsaDec 10, 2012
Director ejecutivoZook (Antony P)
Número de empleados2200
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 10
Dirección9490 Neogenomics Way
CiudadFORT MYERS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33912
Teléfono12397680600
Sitio Webhttps://neogenomics.com/
Símbolo de cotizaciónNEO
Fecha de salida a bolsaDec 10, 2012
Director ejecutivoZook (Antony P)

Ejecutivos de Neogenomics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%

Estadísticas de accionistas

Actualizado: mié., 4 de feb
Actualizado: mié., 4 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Otro
56.71%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Otro
56.71%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.68%
Investment Advisor/Hedge Fund
31.58%
Hedge Fund
23.57%
Research Firm
2.97%
Individual Investor
1.31%
Pension Fund
1.26%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.09%
Family Office
0.04%

Participación institucional

Actualizado: lun., 5 de ene
Actualizado: lun., 5 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
572
134.68M
104.09%
-7.79M
2025Q3
568
127.88M
98.83%
-9.78M
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
17.58M
13.59%
-189.58K
-1.07%
Sep 30, 2025
The Vanguard Group, Inc.
13.87M
10.72%
-227.03K
-1.61%
Sep 30, 2025
First Light Asset Management, LLC
9.93M
7.67%
+3.08M
+45.00%
Sep 30, 2025
Greenhouse Funds LLLP
8.22M
6.35%
+789.51K
+10.62%
Sep 30, 2025
Millennium Management LLC
6.48M
5.01%
+46.65K
+0.72%
Dec 02, 2025
State Street Investment Management (US)
5.02M
3.88%
-88.88K
-1.74%
Sep 30, 2025
Deerfield Management Company, L.P.
4.45M
3.44%
+2.30M
+107.05%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.83M
2.96%
-465.84K
-10.85%
Sep 30, 2025
Schroder Investment Management North America Inc.
3.48M
2.69%
-240.87K
-6.47%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Services ETF
2.38%
Invesco S&P SmallCap Health Care ETF
0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.5%
Inspire Small/Mid Cap ESG ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.14%
iShares S&P Small-Cap 600 Value ETF
0.12%
Nuveen ESG Small-Cap ETF
0.11%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
iShares Core S&P Small-Cap ETF
0.09%
Ver más
State Street SPDR S&P Health Care Services ETF
Proporción2.38%
Invesco S&P SmallCap Health Care ETF
Proporción0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.5%
Inspire Small/Mid Cap ESG ETF
Proporción0.32%
iShares U.S. Healthcare Providers ETF
Proporción0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporción0.14%
iShares S&P Small-Cap 600 Value ETF
Proporción0.12%
Nuveen ESG Small-Cap ETF
Proporción0.11%
iShares ESG Select Screened S&P Small-Cap ETF
Proporción0.1%
iShares Core S&P Small-Cap ETF
Proporción0.09%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI